Rocket Lab launches rockets and builds the guts of satellites. Its little Electron rocket has flown 97 times, but most of its money now comes from space hardware. Now it's buying Iridium's satellite network for $8 billion to become a full-stack space company: build it, launch it, operate it. It's the closest thing to SpaceX you can buy in the public market, which is exactly why the stock is priced like the future already happened.
Scale is 0–50%/yr. The shape of the verdict: the base case doesn't clear the 12% growth bar. Even the bull case needs everything to go right to beat it.
The pitch you hear on Reddit and X is simple: SpaceX went public in June at a $1.77 trillion valuation, and Rocket Lab is the closest thing to SpaceX you can actually buy. The stock ran to $151 in May on that halo, then crashed 53% when the halo faded. The story didn't change, the price did. Retail's shorthand question says it all: if SpaceX is worth $1.77 trillion, what's the second-most-capable space company on Earth worth?
Here's the part the bulls get right and the bears miss: Electron, the little rocket with 97 flights, is now under 20% of revenue. The bigger business is Space Systems: satellite buses, radios, solar panels, separation hardware flown on more than 1,700 missions. Launch is the visible marketing arm; the hardware business is the compounding engine. Anyone analyzing this as 'a rocket company' is fighting the 2021 version.
Neutron is the whole near-term thesis in one vehicle: 13 tons to orbit, partially reusable, with a fairing design the internet nicknamed the Hungry Hippo. It's aimed squarely at the medium-lift market Falcon 9 owns. The problem is it has never flown, the debut has slipped from 2024 to a 'narrowing' Q4 2026 window, and on October 14 the company formally moved first flight into 2027. Beck himself now talks about 'the 10th rocket on the pad.' That's an honest admission: the economics are years away, not one launch away.
The $8 billion Iridium acquisition, expected to close mid-2027, is the most important thing Rocket Lab has ever done. What it buys: L-band spectrum rights, a working satellite network, 2.5 million subscribers, and about $872 million of revenue with $495 million of EBITDA. That's more revenue than Rocket Lab itself, plus profitability it doesn't have. The vision is the closed loop: build the satellites, launch them on your own rockets, operate the network, collect recurring revenue. If it closes cleanly, Rocket Lab wakes up a profitable, vertically integrated space platform.
$2.36 billion, up 137% year over year, with roughly 45% converting to revenue within twelve months and more than 40% from government customers. Five Neutron launches were signed in the first quarter alone, at $50 to $55 million apiece, by customers booking full-price slots on a rocket that hasn't flown. That's either enormous confidence or enormous optimism. Either way, the deposits are real.
Retail's favorite part of the story is Beck himself, and some of the lore is earned. He promised to eat his hat if Rocket Lab ever pursued reusability, then ate it on video when Neutron was announced. He cut his salary to $1 and voluntarily canceled shares worth over $20 million. More importantly: 97 Electron flights with best-in-class reliability, in an industry where new rockets usually blow up. Methodical execution is a genuine edge when your competitors set money on fire for a living.
The contracts stacking up are hard to dismiss: a $397 million Space Force award for missile-tracking satellites, an $816 million Space Development Agency contract, and a Golden Dome missile-defense selection alongside Raytheon. National-security launch (a $5.6 billion program) is exactly the market Neutron is built for. If Golden Dome money starts flowing in 2027, that's a second demand wave retail hasn't fully priced.
From ~$70, the base case reaches roughly $77 by 2031, about 2% a year. That assumes Neutron reaches orbit but cadence and reuse economics take years, Iridium closes with normal integration friction, revenue scales to ~$5 billion, the multiple compresses to ~9x sales as the company matures, and the share count keeps growing through the ATM program. It's a reasonable path. It just doesn't clear either hurdle.
Selective would mean the base case clears 12% a year. It clears about 2%. The 12% bar needs the full bull case (~$180, ~21%/yr): Neutron flying and reflown, Iridium closing cleanly, Golden Dome converting, and the dilution stopping. At $70 you're paying for the fantasy timeline while the company sells $2 billion of stock at half the peak. Watching is the honest label: a real company with real execution, at a price that assumes the future already happened.
Up: a price below ~$42–45, where the base case starts clearing 12% on its own. Or Neutron reaching orbit and the conversation shifting to the economics of the tenth flight. Or Iridium closing cleanly with the combined company inflecting to real EBITDA. Down: Neutron slipping into 2027 with another round of ATM dilution, or the Iridium deal wobbling. The two numbers to watch each quarter: the Neutron schedule language, and the share count.
There is a diligence lens for defense businesses that asks two questions: does the company own a bottleneck, and is there procurement proof? Rocket Lab scores better than any other space name on both. Bottleneck: responsive medium-lift plus flight-proven satellite buses as one system, which the Space Development Agency keeps buying, so the market is confirming the claim. Procurement proof: $816 million in SDA Tracking Layer Tranche 3 (18 satellites, delivery required), $397 million from the Space Force, and a $2.36 billion backlog. That is funded production revenue, not eligibility for future awards. Two honest caveats from the lens itself: Golden Dome follow-ons and the Iridium combination sit in probability-weighted at best, and Neutron economics stay in unfunded optionality until orbit. And the lens scores the business, not the stock: it says what to own, not when. At $70 the verdict is still Watching.
Nothing else matters as much as this. The rocket has never flown, the schedule has already slipped twice, and a first-flight failure (the norm for new vehicles, not the exception) would crater the narrative and the stock. Management's own language has shifted from 'debut flight in Q4' to 'rocket to the pad in Q4.' Read that shift carefully: on October 14 the company made it official and moved first flight into 2027.
The company raised $1.94 billion selling stock at ~$66, less than half the $151 peak, and a $3 billion ATM program is still live. With $134 million of operating cash burn in the first half, the ATM is the funding plan, not a backup. Every dollar raised at these prices costs twice what it cost at the top. Beck himself sold ~3 million shares in July.
Fifty-five to sixty times trailing sales, after a 53% crash, on a $198 million annual loss. There is no earnings floor under this stock. It's all multiple. If growth merely slows from spectacular to good, the multiple compresses and the stock can halve again without the business breaking.
Eight billion dollars is an enormous bet for a $40 billion company, funded largely with equity issued at depressed prices. Running a telecom network is a different business from building rockets, and it doesn't close until mid-2027. If the stock stays weak, the deal's collar mechanics get uglier; if integration stumbles, the 'transformative' acquisition becomes an anchor.
Starship lifts 100-plus tons; Neutron lifts 13. If SpaceX ever gets Starship flying commercially at low cost, the economics of every medium rocket get repriced. Meanwhile there's a securities class action over Neutron timeline disclosures and a protested NASA award. The kind of overhangs that don't matter until they suddenly do.